IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 79 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $122,000 | +29.8% | 54,700 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $94,000 | +8.0% | 54,700 | +55.8% | 0.00% | 0.0% |
| Q1 2017 | $87,000 | +67.3% | 35,100 | +1.4% | 0.00% | – |
| Q4 2016 | $52,000 | -41.6% | 34,600 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $89,000 | +67.9% | 34,600 | 0.0% | 0.00% | – |
| Q2 2016 | $53,000 | +8.2% | 34,600 | +40.7% | 0.00% | – |
| Q1 2016 | $49,000 | +8.9% | 24,600 | +68.5% | 0.00% | – |
| Q4 2015 | $45,000 | +7.1% | 14,600 | +15.9% | 0.00% | – |
| Q3 2015 | $42,000 | -35.4% | 12,600 | -28.4% | 0.00% | -100.0% |
| Q2 2015 | $65,000 | 0.0% | 17,600 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $65,000 | +14.0% | 17,600 | +27.1% | 0.00% | 0.0% |
| Q1 2014 | $57,000 | – | 13,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 474,609 | $626,000 | 0.55% |
| Kassirer Asset Management Corp | 325,800 | $430,000 | 0.28% |
| CORRADO ADVISORS, LLC | 104,850 | $138,000 | 0.08% |
| Artal Group S.A. | 2,750,000 | $3,630,000 | 0.08% |
| ROPES WEALTH ADVISORS LLC | 100,000 | $132,000 | 0.04% |
| MYCIO WEALTH PARTNERS, LLC | 246,527 | $325,000 | 0.03% |
| Palo Alto Investors LP | 616,355 | $814,000 | 0.03% |
| HOLLENCREST CAPITAL MANAGEMENT | 172,570 | $228,000 | 0.03% |
| LAU ASSOCIATES LLC | 26,713 | $35,000 | 0.02% |
| NATIXIS | 3,438,529 | $4,539,000 | 0.02% |